Valuation: Vineet Laboratories Limited

Market Cap 56Cr 58.48L 50.69L 47.52L 43.33L 81.53L 82.83L 5.6Cr 2.18Cr 28Cr 2.2Cr 2.15Cr 93Cr P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 96Cr 1Cr 86.78L 81.35L 74.18L 1.4Cr 1.42Cr 9.58Cr 3.74Cr 48Cr 3.76Cr 3.68Cr 159.56Cr EV / Sales 2024
5,87,502x
EV / Sales 2025 8,90,202x
Free-Float
63.66%
Yield 2024 *
-
Yield 2025 -
21/07 Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026 CI
29/05 Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026 CI
14/02 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
07/02 Vineet Laboratories Limited Approves Appointment of Jasmin Kunal Tailor as Independent Director CI
17/12 Vineet Laboratories says rights issue price set at 30 rupees per share RE
27/11 Vineet Laboratories Gets Board Nod to Raise Up to INR300 Million via Rights Issue MT
27/11 Vineet Laboratories to raise funds up to 300 million rupees via rights issue RE
24/11 Vineet Laboratories to consider rights issue RE
08/11 Vineet Laboratories Limited Announces Resignation of Hari Priya Yerukalapudi as Independent Director, Effective November 08, 2025 CI
16/25/16 Vineet Laboratories Limited Approves the Appointment of Premananda Reddy Vennapusa as Non-Executive Director, Effective from September 15, 2025 CI
22/25/22 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
12/25/12 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/24/13 Vineet Laboratories Limited Announces Resignation of Bhaskara Reddy Karna as Independent Director CI
1 day-1.95%
1 week+1.89%
Current month-4.90%
1 month+8.84%
3 months+5.99%
6 months+22.73%
Current year+2.47%
1 week 35.01
Extreme 35.01
40
1 month 33.2
Extreme 33.2
40.2
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
94.95
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Director of Finance/CFO 76 01/01/2021
Human Resources Officer - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 57 10/11/2016
Director/Board Member 76 10/11/2016
Chairman 73 16/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.66%+1.89%+9.47%-27.10% 77.36L
-0.92%+1.43%+83.05%+128.86% 1,07800Cr
+0.47%+1.98%+50.26%+50.75% 63TCr
+0.83%+2.85%+24.49%+64.82% 44TCr
-0.97%-2.10%+43.78%+35.77% 36TCr
-1.15%-2.86%+24.16%+34.60% 29TCr
-1.52%-2.99%-0.40%+3.83% 25TCr
+0.40%+3.21%+44.42%+59.17% 23TCr
+1.02%-1.23%-7.13%-51.34% 20TCr
+1.67%+5.56%+14.98%+72.68% 17TCr
Average -0.23%+1.22%+28.71%+37.20% 36.44TCr
Weighted average by Cap. -0.23%+1.30%+45.48%+65.51%

Financials

2024 2025
Net sales 1.51T 15.82 13.71 12.85 11.72 22.05 22.4 151.34 59.08 755.69 59.38 58.1 2.52T 769.53 8.06 6.99 6.55 5.97 11.24 11.42 77.14 30.12 385.21 30.27 29.62 1.29T
Net income 1.03Cr 1L 93.28T 87.45T 79.73T 2L 2L 10.3L 4L 51.41L 4L 4L 1.72Cr -20Cr -21.16L -18.34L -17.19L -15.67L -29.49L -29.97L -2.02Cr -79.02L -10Cr -79.43L -77.71L -34Cr
Net Debt 44Cr 46.18L 40.03L 37.52L 34.21L 64.37L 65.41L 4.42Cr 1.72Cr 22Cr 1.73Cr 1.7Cr 74Cr 40Cr 41.64L 36.09L 33.83L 30.85L 58.05L 58.98L 3.98Cr 1.56Cr 20Cr 1.56Cr 1.53Cr 66Cr
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
14/26/14 37.80 -1.66% 38,559
13/26/13 ₹38.44 -1.39% 83,321
12/26/12 ₹38.98 +4.14% 73,758
11/26/11 ₹37.43 +4.99% 41,991
10/26/10 ₹35.65 -3.62% 65,828
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock